Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours
VEGF-R1 may be a potential biomarker useful in assessing the effectiveness of PRRT in NET patients.
Authors
- Beata Kos‐Kudła (ORCID: https://orcid.org/0000-0003-3755-1722)
- Violetta Rosiek (ORCID: https://orcid.org/0000-0002-5238-9287)
- Karolina Makulik
- Dariusz Kajdaniuk (ORCID: https://orcid.org/0000-0002-5577-800X)
- Monika Wójcik-Giertuga (ORCID: https://orcid.org/0000-0003-3983-6270)
- Grzegorz Kamiński (ORCID: https://orcid.org/0000-0002-2357-0634)
- Janusz Strzelczyk (ORCID: https://orcid.org/0000-0002-7987-7344)
Institutions
- Medical University of Silesia (PL)
Publication Details
- Journal
- Endokrynologia Polska
- Published
- 2024-08-09
- DOI
- https://doi.org/10.5603/ep.100241
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00